DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Thursday 29 October 2015

Mohammad Aslam


Mohammad Aslam

Mohammad Aslam

Chemicals Professional
Houston, Texas Area

LINKS

https://www.linkedin.com/pub/mohammad-aslam/9/57a/abb

aslam53000@yahoo.com



Experience











V. P. R&D

Lonza
(4 years)



Education










Western University

Ph.D., Chemistry

Mohammad Aslam,
Postdoctoral Fellow, 1982-1986, aslam53000@yahoo.com



College of Arts and Sciences



 maslam





























 BY HIM...........

I  completed my Ph.D. at the University of Western Ontario in London, Canada under the direction of Professor James F. King in 1982. 

 Immediately after completing the Ph.D., I joined Professor Eric Block’s Research Group in Albany as a Post-doctoral fellow, remaining there until 1986.


My first industrial position was with Celanese Corporation of America as a Research Chemist in Corpus Christi, Texas.

 In 1987 Hoechst acquired Celanese and the company became Hoechst Celanese. At Hoechst Celanese, I developed chemical processes to make pharmaceutical fine chemicals, pharmaceutical intermediates as well as polymer intermediates in various capacities including Group Leader and Program Manager. In 1997 Hoechst closed the R&D Center in Corpus Christi and I was transferred to Frankfurt, Germany. In Frankfurt I lead a group of chemists and chemical engineers responsible for improving the manufacturing processes of commercial agricultural chemicals including herbicides, insecticides and fungicides.


In 1998, I returned to Morristown, New Jersey and took a position with Allied Signal (now Honeywell) as a Technology Leader for the pharmaceutical fine chemicals group.

This was a short tenure since I was offered a position as a Vice President of R&D for the Specialty Chemicals Group at Lonza, USA in Annandale, New Jersey. At Lonza the R&D team developed biocides, water treatment and wood preservation chemicals for household and industrial applications. During my tenure at these companies I received 33 U.S. Patents as an inventor or a co-inventor. I stayed at Lonza until 2003 when I relocated to Corpus Christi with my family.

After returning to Corpus Christi, I took a position in pharmaceutical sales, which was transferred to Houston, Texas in 2005. I left the sales position in 2008 and helped my wife (Ambreen) in setting up her medical practice (Pediatrician) which I am now managing.




Dr.Ambreen Aslam Child Pediatrics







Luv-N-Care Pediatrics Northwest Houston Texas, Luv-N-Carepediatrics Houston, TX

– Present (20 years 10 months)11037 FM 1960 Suite B-2A Houston, TX 77065, United States......Luv-N-Care Pediatrics as your pediatric practice where we are committed to serving the Cypress-Fairbanks area and the Northwest Houston area. As providers of pediatric care we strive to provide an excellent experience for growing families........... http://www.luv-n-carepediatrics.com/index.html


We are blessed with three beautiful daughters Asra, Hira (twins 16 years) and Sidra (13 years). Asra and Hira are in 11th grade and Sidra is in 8th grade (2013).




L to R, Mohammad Aslam, Venkatachalam Eswarakrishnan, Raji Iyer, Saleem Ahmad, Alan (Greg) Wall


L to R, Kaluo Tang, Raji Iyer, Venkatachalam Eswarakrishnan, Saleem Ahmad, Mohammad Aslam.





 1986-2
L to R, , Eric Block, Mohammad Aslam



 

Ambreen Aslam, M.D., FAAP

Dr. Aslam is board certified in Pediatrics and is a member of the American Academy of Pediatricians. Dr. Aslam has privilages at
Cy-Fair Medical Center, where she has also served as head of the pediatrics departments during years 2011 and 2012. Dr. Aslam is also appointed as Clinical Assistant Professor for UTMB Department of Pediatrics to teach their medical and PA students. Dr. Aslam was recognized as one of the leading physicians in World & Top Physicians in Houstion, TX by International Associate of Pediatricians in 2012.

Dr. Ambreen Aslam has more than 15 years of experience practicing pediatrics in Texas and New Jersey. She is dedicated to provide comprehensive pediatric healthcare from infancy to adolescence. Dr. Aslam completed her postgraduate training at Driscoll Children's Hospital in Corpus Christi, Texas.

She is well liked by parents and children. Dr. Aslam is the recipient
of the Physician Recognition Award in Continuing Medical Education from American Medical Association. She has been recognized as one of the Best Doctors by Better Living Magazine in New Jersey.

She is married and blessed with three beautiful daughters and enjoys reading, traveling and listening to music.
Image result for LUV-N-CARE PEDIATRICS
 Pediatrics Child Health Care Houston
Pediatrics Care Cypress-Fairbanks




 Address:
11811 Fallbrook Dr., Suite B-2, Houston, TX 77065.


http://www.luv-n-carepediatrics.com/links.php

Dr.Ambreen Aslam on twitter

@Childpediatrics

ambreen

@ambreen07227164





///////

Wolfgang Reinhard Ludwig Notz

Wolfgang Notz

Wolfgang Reinhard Ludwig Notz

Principal Scientist Process Chemistry/CMC at Takeda Pharmaceuticals
Takeda Pharmaceutical Company Limited 
One Takeda Parkway
Deerfield , Illinois 60015
United States
USA

Germany


LINKS

Experience

Principal Scientist

Takeda Pharmaceuticals
February 2008 – Present (7 years 9 months)
Process Chemistry
Located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.

Senior Scientist

BioVerdant Inc
June 2006 – January 2008 (1 year 8 months)
Process Research & Development; New Route development; biocatalysis; enzymes in chemical synthesis; design of cost-effective API synthesis using enzyme technolgy as key tool

Principal Scientist

Pfizer Inc
November 2001 – May 2006 (4 years 7 months)
process research and development
 

Education

The Scripps Research Institute

Post-Doc, Direct asymmetric organocatalysis
1999 – 2001
Proline/amine catalyzed direct asymmetric aldol and Mannich reactions

Universität Konstanz

PhD, Synthetic organic chemistry
1996 – 1999
Development of a general strategy toward C-ketosides of sialic acids;
De novo synthesis of the Neu5Ac-alpha-2,3-galactose C-disaccharide
Map of university of konstanz

Patents by Wolfgang Reinhard Ludwig Notz

http://www.google.com/patents/US8835420
Figure US08835420-20140916-C00010
Patent number: 8835420
Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with PI3K?.
Type: Grant
Filed: July 8, 2013
Issued: September 16, 2014
Assignee: Takeda Pharmaceutical Company Limited
Inventors: Edcon Chang, Wolfgang Reinhard Ludwig Notz, Michael B. Wallace
Application number: 20140018344
Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with PI3K?.
Type: Application
Filed: July 8, 2013
Issued: January 16, 2014
Inventors: Edcon Chang, Wolfgang Reinhard Ludwig Notz, Michael B. Wallace
Application number: 20120172321
Abstract: The invention relates to HSP90 inhibiting compounds consisting of the formula: wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Type: Application
Filed: March 1, 2012
Issued: July 5, 2012
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors: Young K. Chen, Erick Co, Prasuna Guntupalli, John D. Lawson, Wolfgang Reinhard Ludwig Notz, Jeffrey A. Stafford, Huong-Thu Ton-Nu
Patent number: 8071766
Abstract: The invention relates to HSP90 inhibiting compounds consisting of the formula: wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Type: Grant
Filed: January 30, 2009
Issued: December 6, 2011
Assignee: Takeda Pharmaceutical Company Limited
Inventors: Young K. Chen, Erick Co, Prasuna Guntupalli, John D. Lawson, Wolfgang Reinhard Ludwig Notz, Jeffrey A. Stafford, Huong-Thu Ton-Nu
Application number: 20110053873
Abstract: The invention relates to HSP90 inhibiting compounds consisting of the formula: (I) wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Type: Application
Filed: January 30, 2009
Issued: March 3, 2011
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors: Young K. Chen, Eric Wang Co, Prasuna Guntupalli, John David Lawson, Wolfgang Reinhard Ludwig Notz, Jeffrey A. Stafford, Huong-Thu Ton-Nu
Application number: 20090305998
Abstract: The invention relates to HSP90 inhibiting compounds consisting of the formula: wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Type: Application
Filed: January 30, 2009
Issued: December 10, 2009
Assignee: Takeda Pharmaceutical Company Limited
Inventors: Young K. Chen, Erick Co, Prasuna Guntupalli, John D. Lawson, Wolfgang Reinhard Ludwig Notz, Jeffrey A. Stafford, Huong-Thu Ton-Nu
Application number: 20040266796
Abstract: The invention relates to processes for the preparation of a GARFT inhibitor containing a methyl substituted thiophene core having the following structure: 1
Type: Application
Filed: June 23, 2004
Issued: December 30, 2004
Assignee: AGOURON PHARMACEUTICALS, INC.
Inventors: Elena Dovalsantos, Erik Jon Flahive, Brian John Halden, Mark Bryan Mitchell, Wolfgang Reinhard Ludwig Notz, Stacy Ann O'Neill-Slawecki, Qingping Tian
Application number: 20040266827
Abstract: The invention relates to processes for the preparation of a key intermediate in the synthesis of a GARFT inhibitor of formula (Ia) containing a 4-methyl-substituted thiophene core: 1
Type: Application
Filed: June 16, 2004
Issued: December 30, 2004
Assignee: AGOURON PHARMACEUTICALS, INC.
Inventors: Wolfgang Reinhard Ludwig Notz, Carlos Alberto Martinez

https://33.media.tumblr.com/1ccca0c990f7ce76796c2c2b35cb7f49/tumblr_noi3n89RZi1ur8m7ho1_500.gif











///Wolfgang Notz

Loredana cappellacci

Loredana Cappellacci

Loredana cappellacci

Professor (Associate)
School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, Via S. Agostino 1, 62032 Camerino

LINKS
Loredana Cappellacci is Associate Professor of Medicinal Chemistry, School of Pharmacy, at University of Camerino.
She started her research activity with Prof Grifantini at the Department of Chemical Sciences, University of Camerino since 1989.
Fellow (January 3, 1989 – March 15, 1993),
then Researcher in Medicinal Chemistry (CHIM/08) (March 16, 1993 – September 30, 2007),
and Associate Professor in Medicinal Chemistry (CHIM/08) since October 1, 2007 at the School of Pharmacy, University of Camerino.
In September 2004, she was selected as suitable to be Associate Professor of Medicinal Chemistry at University of Modena and Reggio Emilia.
Visiting Scientist at SOUTHERN RESEARCH INSTITUTE in Birmingham, Alabama, USA, (July 28, 1997- August 6, 1998) working in the team of Prof. John A. SECRIST III on a research project under the auspices of a NIH grant that supported research designed to develop new anticancer drugs.
One of the synthesized compounds, 4'-thio-araC (Thiarabine), has been recently licensed to Assess Pharmaceuticals Inc. and is in phase I/II of clinical development for treatment of solid tumors and in phase II for treatment of lymphoma and leukaemia, and more recently preclinical data demonstrated its remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA).
Supervisor of PhD theses in Medicinal Chemistry (2006-2009 and 2012-2013).
Delegate for Tutorship at Faculty of Pharmacy (November 19, 2008 - January 25, 2012).
Coordinator of Chemistry and Pharmaceutical Technology degree course since December 2009. Rector’s Delegate for “Valorizzazione di Studenti e Alumni: Ambientamento e Tutorato”, since November 3, 2011.
Member of the Organizing Committee of the International Meeting “THIRD JOINT ITALIANGERMAN PURIN CLUB MEETING Purinergic Receptors: New Frontiers for Novel Therapies”, held in Camerino on July 17-20, 2009. Participant in research projects on AIDS funded by Italian Ministry of Health (1991-2001) and National Ministry of University and Scientific Research (PRIN 1997, 2002, 2004, 2006).
Currently, Local Scientific Coordinator of a research project financed by MIUR (PRIN 2009). Peer reviewer of international journals: Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic Medicinal Chemistry and Antioxidants & Redox Signaling and of a National Medical Research Council (NMRC) Research Grant Proposal.
She is member of Purine Club and Medicinal Chemistry Division of the Italian Chemical Society. Loredana Cappellacci is author of 71 publications in leading international peer-review journals, one Patent in the anti-HIV drugs’ field, one U.S. Patent in the antitumor drugs’ field and more than 130 communications to national and international meetings.
A recent published paper (J. Med. Chem. 2009, 52, 2393-2406) has been cited by Nature (SciBX 2(14); doi:10.1038/scibx.2009.592) and has been praised by local and international newspapers.
Her scientific interests focus on: 1) nucleosides and nucleotides as antitumor and antiviral agents and their prodrugs; 2) enzyme inhibitors as antitumor and, more recently, as antimicrobial agents; 3) adenosine receptor (AR) ligands, in particular A1AR agonists, useful in the treatment of neuropathic pain.


RESEARCH EXPERIENCE

  • Oct 2007- Jun 2015, Professor (Associate)
    · University of Camerino School of Pharmacy, Medicinal Chemistry Unit
    Italy · Camerino
  • Jul 1997- Aug 1998 , Visiting Professor
    Southern Research Institute · Prof. John A. Secrist III
    · United States Birmingham
  • Jan 1990- Oct 2007 , Assistant profesor
    · University of Camerino School of Pharmacy Medicinal Chemistry Unit
    Italy · Camerino

OTHER

////////Loredana cappellacci

Ghassan Abu Sheikha

Ghassan Abu Sheikha


Dean, Faculty of Pharmacy at 

 

Al-Zaytoonah University of Jordan

Department of Pharmaceutical Sciences
Telephone: + 962- 79- 5803339 Faculty of Pharmacy
FAX: +962- 6- 4291432
Al-Zaytoonah University of Jordan
E-Mail: gmabusheikha@yahoo.com
P.O. Box 130 Amman 11733 Jordan
(Tel 00962 64291511), e-mail: ztipc2015@zuj.edu.jo
LINKS
Ghassan Abu Sheikha
ABOUT DR. GHASSAN ABU SHEIKHA
Professor Ghassan M. Abu Shaikha obtained a Ph.D. degree in Medicinal Chemistry from University of Pisa- Italy , and a Bachelor degree in Pharmacy and Bachelor degree in Pharmaceutical Chemistry and Technology from University of Camerino - Italy . He started his professional life in Faculty of Pharmacy in University of Camerino – Italy as Assistant Research Professor, then as Assistant Professor of Medicinal Chemistry in Faculty of pharmacy in applied science university in Amman Jordan. He joined the academic team in the faculty of pharmacy in Al Zaytoonah university in 2005 as the dean of the faculty. where he taught various undergraduate and graduate courses and supervised around twenty five masters and Ph.D. students. Currently, he is a full professor of medicinal chemistry. His professional experience includes consultancy and advisory work for industry, research laboratories, and governmental institutions. He is a Member of American Association of Colleges of Pharmacy (AACP) since 2013 to present and an advisory member and Reviewer for Jordan Journal of Pharmaceutical Sciences



EDUCATION AND TRAINING
Ph.D in Medicinal Chemistry 1993 - 1997 Advisor: Professor Palmarisa Franchetti University of Pisa Italy B.S. Pharmacy 1992 - 1993 University of Camerino Italy
B.S. Pharmaceutical Chemistry and Technology 1985 - 1992 University of Camerino Italy
EMPLOYMENT
Visiting Research Scholar June 2013 - Aug 2013 College of Pharmacy and Pharmaceutical Sciences University of Toledo Toledo, OH
UT ShieldThe University of ToledoUTCPPS logo
Dean July 2011 - present Professor of Medicinal Chemistry Faculty of Pharmacy Al-Zaytoonah University Amman, Jordan
Dean Sept 2005 - July 2011, Associate Professor of Medicinal Chemistry Faculty of Pharmacy Al-Zaytoonah University Amman, Jordan
Associate Professor of Medicinal Chemistry Aug 2004 - Aug 2005 College of Pharmacy, King Khalid University Abha, Saudi Arabia
Associate Professor of Medicinal Chemistry Feb 2004 - Aug 2004 Faculty of Pharmacy Philadelphia University Amman, Jordan
Dean Feb 2003 - Oct 2003 Associate Professor of Medicinal Chemistry Faculty of Pharmacy Applied Science University Amman, Jordan
Dean Assistant Professor of Medicinal Chemistry July 2002 - Feb 2003 Faculty of Pharmacy Applied Science University Amman, Jordan
Deputy Dean Assistant Professor of Medicinal Chemistry Aug 2001 - Oct 2001 Faculty of Pharmacy Applied Science University Amman, Jordan
Assistant Professor of Medicinal Chemistry Sept 1998 - Feb 2003 Faculty of Pharmacy Applied Science University Amman, Jordan
Assistant Research Professor July1997– April 1998 Faculty of Pharmacy Camerino University Camerino, Italy
PROFESSIONAL ACTIVITY
Summary of research interest
 Synthesis of anti-hyperlipidemia agents.  Synthesis of acyclic nucleoside phosphonates as anti- HIV-1 (antivirals).  Synthesis of nucleoside analogues as anti-cancer and antiviral.
Ghassan Abu Sheikha
PUBLISHED ABSTRACTS
1. FloHet-2013 Florida Heterocyclic and Synthetic Conference, March 3rd -March 6th, 2013, Gainesville, Florida, USA.
2. The Sixth International Conference of the Royal Medical Services, King Hussein Bin Talal Convention Center ,10-12 November 2012, Dead Sea, Jordan.
3. Faculties of Pharmacy at Al-Zaytoonah University of Jordan and The University of Toledo International Pharmaceutical Conference (ZTIPC 2012), 17-19 October 2012, Amman, Jordan.
Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin
P Franchetti, L Cappellacci, GA Sheikha, HN Jayaram, VV Gurudutt, T Sint, ...
Journal of medicinal chemistry 40 (11), 1731-1737
561997
Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads
A Al-Nadaf, GA Sheikha, MO Taha
Bioorganic & medicinal chemistry 18 (9), 3088-3115
452010
Synthesis and evaluation of the anti-HIV activity of aza and deaza analogs of isoddA and their phosphates as prodrugs
P Franchetti, L Cappellacci, M Grifantini, L Messini, GA Sheikha, AG Loi, ...
Journal of medicinal chemistry 37 (21), 3534-3541
351994
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration
RA Khalaf, GA Sheikha, Y Bustanji, MO Taha
European journal of medicinal chemistry 45 (4), 1598-1617
312010
Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits
MO Taha, M Tarairah, H Zalloum, G Abu-Sheikha
Journal of Molecular Graphics and Modelling 28 (5), 383-400
222010
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus
P Franchetti, GA Sheikha, L Cappellacci, S Marchetti, M Grifantini, ...
Antiviral research 47 (3), 149-158
222000
Synthesis and antiviral activity of 8-aza analogs of chiral [2-(phosphonomethoxy) propyl] guanines
P Franchetti, G Abu Sheikha, L Cappellacci, M Grifantini, A De Montis, ...
Journal of medicinal chemistry 38 (20), 4007-4013
201995
A new class of acyclic nucleoside phosphonates: synthesis and biological activity of 9-{[(phosphonomethyl) aziridin-1-yl] methyl} guanine (pmamg) and analogues
GA Sheikha, P La Colla, AG Loi
Nucleosides, Nucleotides and Nucleic Acids 21 (10), 619-635
162002
Preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis
RM Obaidat, A Bader, W Al-Rajab, GA Sheikha, AA Obaidat
Scientia pharmaceutica 79 (1), 197
152011
8-Aza-analogues of PMEA and PMEG: Synthesis and in vitro anti-HIV activity
P Franchetti, GA Sheikha, L Cappellacci, L Messini, M Grifantini, AG Loi, ...
Nucleosides, Nucleotides & Nucleic Acids 13 (8), 1707-1719
131994
Synthesis and Anti-Hyperlipidemic Evaluation of N‑(Benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide Derivatives in Triton WR-1339-Induced Hyperlipidemic Rats
G Shattat, R Al-Qirim, Y Al-Hiari, GA Sheikha, T Al-Qirim, W El-Huneidi, ...
Molecules 15 (9), 5840-5849
112010
Homology modeling of MCH1 receptor and validation by docking/scoring and protein-aligned CoMFA
A Abu-Hammad, WA Zalloum, H Zalloum, G Abu-Sheikha, MO Taha
European journal of medicinal chemistry 44 (6), 2583-2596
112009
Acyclic nucleotides related to clitocine: Synthesis and anti-HIV activity
P Franchetti, L Cappellacci, GA Sheikha, M Grifantini, AG Loi, AD Montis, ...
Nucleosides, Nucleotides & Nucleic Acids 14 (3-5), 607-610
91995
In Vivo Antihyperlipidemic Activity of a New Series of N‐(Benzoylphenyl) and N‐(Acetylphenyl)‐1‐benzofuran‐2‐carboxamides in Rats
T Al‐Qirim, G Shattat, K Sweidan, W El‐Huneidi, GA Sheikha, RA Khalaf, ...
Archiv der Pharmazie 345 (5), 401-406
72012
Novel derivatives of 1, 3-dimethyl-5-methylenebarbituric acid
K Sweidan, Q Abu-Salem, A Al-Sheikh, GA Sheikha
Letters in Organic Chemistry 6 (8), 669-672
62009
Pharmacological evaluation of novel indole-2-carboxamides as potent lipid-lowering agents in Triton-WR-1339-induced hyperlipidemic rats
T Al-Qirim, M Shahwan, G Shattat, Y Al-Hiari, GA Sheikha, S Zaidi
Zeitschrift für Naturforschung C 64 (9-10), 619-625
52009
Synthesis and characterization of water-soluble palladium (II)-functionalized diphosphine complexes
M Sunjuk, M Al-Noaimi, GA Sheikha, E Lindner, B El-Eswed, K Sweidan
Polyhedron 28 (8), 1393-1398
52009
Synthesis of Unsaturated Analogues of 9-[2 (Phosphono-Methoxy) Propyl] Guanine as Antiviral Agents
P Franchetti, GA Sheikha, P Perlini, F Farhat, M Grifantini, G Perra, C Milia, ...
Nucleosides, Nucleotides & Nucleic Acids 16 (10-11), 1921-1932
51997
Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation
GA Sheikha, MA Al-Sha’er, MO Taha
Journal of enzyme inhibition and medicinal chemistry 26 (5), 603-609
42011
Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats
Y Al-Hiari, G Shattat, T Al-Qirim, W El-Huneidi, GA Sheikha, S Hikmat
Molecules 16 (10), 8292-8304

Ghassan Abu Sheikha, Dean of Faculty of Pharmacy at Al-Zaytoonah University (Tel 00962 64291511), e-mail: ztipc2015@zuj.edu.jo or from the conference ...









///////Ghassan Abu Sheikha,